CARLSBAD, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (“NAI”) (NASDAQ:NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, announced it has extended its partnership with The Juice Plus+ Company (“Juice Plus+”), a globally recognized leader in plant-based whole-body nutritional products, through the execution of a new multi-year Manufacturing Agreement covering Juice Plus+ capsule and powder products sold in over 24 markets aroun ...

Core Insights - Lifeist Wellness Inc. has launched three new Mikra performance-focused daily essentials aimed at enhancing cognitive performance and mental resilience [1][2] - The new products include Magnesium Bis-Glycinate, Coenzymated B Complex, and Omega-3 with EPA & DHA, all manufactured in partnership with Designs for Health [1][5] - The introduction of these products aligns with Mikra's Mind-First Movement, which emphasizes mental performance as a foundation for overall high performance [2][6] Product Details - Magnesium Bis-Glycinate is designed to ease physical tension and support recovery by calming the nervous system, which is crucial for cognitive performance [5] - Coenzymated B Complex provides active forms of B vitamins that help in energy production and stress regulation, contributing to cognitive stamina and mood balance [5] - Omega-3 with EPA & DHA nourishes brain cell membranes and supports mood regulation, playing a vital role in cognitive clarity and emotional steadiness [5] Strategic Partnerships - Lifeist has partnered with Designs for Health, a company known for its high-quality nutritional supplements and commitment to research-driven formulations [4][2] - This collaboration aims to integrate clinical precision with real-world performance, enhancing the quality and effectiveness of Mikra's product offerings [2][4] Brand Philosophy - Mikra operates under the philosophy that the mind leads and the body follows, focusing on the connection between mental and physical performance [5][6] - The brand aims to set a new standard for total human performance by prioritizing cognitive and emotional resilience through targeted formulations [6]

Mikra partners with leading nutritional supplement brand Designs for Health to introduce new product formulations TORONTO, July 21, 2025 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSX.V: LFST; OTCQB: LFSWF; FRANKFURT: M5B0), a health-tech wellness company curating and building innovation at the forefront of consumer health, announces the availability of three new Mikra performance-focused daily essentials on wearemikra.com. The new products — Magnesium Bis-Glycinate, Coenzymated ...

Tensions between the US and China escalating beyond the trade war. From tech, China is a competitor to Taiwan and remember that spy balloon. State of our union is apparently under Chinese surveillance.Washington now working to defend the US military from surveillance. Congress and the president trying to prevent China from buying land near bases over national security concerns. And now one lawmaker saying the country is already inside them through a nutritional company selling protein powder and vitamins to ...

Company Overview - Nature's Sunshine Products, Inc. (NASDAQ: NATR) is a leading manufacturer of high-quality herbal and nutritional supplements [1][3] - The company markets and distributes nutritional and personal care products in over 40 countries [3] Upcoming Conference Call - Nature's Sunshine will conduct a conference call on July 31, 2025, at 5:00 p.m. Eastern time to discuss its financial results for the second quarter ended June 30, 2025 [1][2] - The call will be hosted by CEO Terrence Moorehead and CFO Shane Jones, followed by a question and answer period [2] Financial Results Announcement - The company will release its financial results in a press release prior to the conference call [1] - A replay of the conference call will be available after 8:00 p.m. Eastern time on the same day through August 14, 2025 [3] Contact Information - Investor relations can be reached through Gateway Group, Inc. at 1-949-574-3860 [4]

Core Viewpoint - The dispute between Weihai Baihe Biotechnology Co., Ltd. (Baihe) and Shandong Hailaiyunshi Co., Ltd. (Hailaiyunshi) has raised concerns over potential commercial bribery, impacting Baihe's market image and future prospects [1][2][3] Group 1: Dispute Background - The conflict originated from a discarded contract signed in December 2020 for the production of oat bran and other meal replacement products [1] - Baihe completed production tasks as per orders in January and March 2021, but Hailaiyunshi ceased issuing new production instructions by the end of March 2021 [1] - In 2024, Baihe claimed that a batch of raw materials prepared for the contract had expired and demanded compensation from Hailaiyunshi, leading to a lawsuit after failed negotiations [1] Group 2: Evidence of Bribery - During the lawsuit, Hailaiyunshi's lawyer discovered a record of a payment of 0.6 yuan per box to Baihe's procurement personnel, potentially amounting to 360,000 yuan based on an annual purchase volume of 600,000 boxes [2] - Key personnel at Baihe, including the vice president and auditors, approved this arrangement, raising suspicions of commercial bribery [2][3] Group 3: Company Performance and Responsibilities - Baihe, known as the "first stock of nutritional health food OEM," reported a revenue of 801 million yuan in 2024, with 84% of this revenue coming from its OEM business [5] - The company faced a revenue decline of 8.02% year-on-year and a net profit drop of 17.60% in 2024, attributed to global economic fluctuations and domestic market adjustments [5] - Baihe is obligated to disclose information regarding the incident, internal investigations, and corrective measures to the market and investors [5]

Core Insights - Luma Nutrition's flagship product, Magnesium Glycinate 1000mg, has surpassed 10,000 units sold per month on Amazon, indicating strong consumer demand for effective wellness solutions [1][2] - The product is recognized for its high absorption, purity, and effectiveness in supporting various health benefits, including restful sleep and mental clarity [1][4] Product Overview - Magnesium Glycinate is a chelated form of magnesium that is highly absorbable and gentle on the stomach, making it suitable for individuals seeking effective supplementation without gastrointestinal discomfort [4] - The product is manufactured in FDA-registered facilities, complies with GMP standards, and is third-party tested for quality assurance [5][20] Health Benefits - Magnesium plays a crucial role in over 300 biochemical processes, supporting muscle function, nerve signaling, heart rhythm, and bone development [3] - Key benefits of Luma Nutrition's Magnesium Glycinate include alleviating muscle cramps, supporting cardiovascular health, boosting bone structure, and helping manage anxiety [10][11][12][13] - Users can expect improvements in sleep quality, stress relief, muscle recovery, and enhanced mental clarity over time [8][9] Usage Recommendations - For optimal results, it is recommended to take 2 capsules in the evening with food consistently for 1-3 months to allow the body to rebalance magnesium levels [6] - Initial support and relaxation can be expected within 1-2 months, with deeper health benefits emerging over 3-6 months [7] Customer Feedback - Customer reviews indicate that the supplement is effective for improving sleep quality and managing stress, with many users reporting noticeable benefits within a few weeks [24] - Some customers mention a higher price point compared to similar products and occasional mild gastrointestinal discomfort, though overall feedback is positive [25] Market Position - Luma Nutrition's Magnesium Glycinate is positioned as one of the best magnesium glycinate supplements available in Canada and the United States, backed by a 90-day satisfaction guarantee [15][18] - The company emphasizes quality, sourcing premium ingredients, and adhering to high production standards to ensure customer trust and satisfaction [14][20]

Core Viewpoint - Nature's Sunshine Products, Inc. is conducting a secondary public offering of up to 2,854,607 shares at a price of $12.00 per share, with the offering expected to close on June 27, 2025 [1][2]. Group 1: Offering Details - The Selling Stockholder, Fosun Pharma USA, Inc., will receive all net proceeds from the offering, while Nature's Sunshine will not sell any shares or receive any proceeds [2]. - The Company has agreed to potentially purchase up to $15.0 million of its common stock from the underwriters as part of its share repurchase program, but there is no guarantee that any shares will be purchased [3]. - D.A. Davidson & Co. is acting as the sole book-running manager for the offering, which is made under a shelf registration statement filed with the SEC [4]. Group 2: Company Background - Nature's Sunshine Products is a leading manufacturer of herbal and nutritional supplements, distributing products in over 40 countries and ensuring high quality through its own manufacturing facilities [8].

Core Viewpoint - Nature's Sunshine Products, Inc. is launching a secondary public offering of up to 2,854,607 shares of its common stock, which will be sold by Fosun Pharma USA, Inc. as the selling stockholder [1][2]. Group 1: Offering Details - The selling stockholder will receive all net proceeds from the offering, while Nature's Sunshine will not sell any shares or receive any proceeds [2]. - The company has agreed to potentially purchase up to $15.0 million of its common stock from the underwriters as part of its share repurchase program, but there is no guarantee that any shares will be purchased [3]. - D.A. Davidson & Co. is acting as the sole book-running manager for the offering, which is being conducted under a shelf registration statement filed with the SEC [4]. Group 2: Company Background - Nature's Sunshine Products is a leading manufacturer of herbal and nutritional supplements, marketing products in over 40 countries and ensuring high quality through its own manufacturing facilities [8].

Core Viewpoint - USANA Health Sciences (USNA) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook based on an upward trend in earnings estimates, which significantly influences stock prices [1][4]. Earnings Estimates and Stock Ratings - The Zacks rating system is primarily driven by changes in a company's earnings picture, with the Zacks Consensus Estimate tracking EPS estimates from sell-side analysts [2]. - The correlation between earnings estimate revisions and near-term stock price movements makes the Zacks rating system valuable for investors, as it provides a clearer picture than subjective Wall Street analyst ratings [3][7]. Institutional Investor Influence - Institutional investors play a role in the relationship between earnings estimates and stock prices, as they adjust their valuations based on these estimates, leading to significant stock transactions that affect price movements [5]. Business Improvement Indicators - Rising earnings estimates and the Zacks rating upgrade for USANA Health suggest an improvement in the company's underlying business, which could lead to increased stock prices as investors respond positively [6]. Earnings Estimate Revisions for USANA Health - For the fiscal year ending December 2025, USANA Health is expected to earn $2.61 per share, with no year-over-year change, but the Zacks Consensus Estimate has increased by 1.8% over the past three months [9]. Zacks Rank System Performance - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [8]. - The upgrade of USANA Health to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating strong potential for market-beating returns in the near term [11].